Richard Lafayette
Academic Appointments
- Associate Professor - Med Center Line, Medicine - Nephrology
Contact Information
-
Clinical Offices
Nephrology Clinic 300 Pasteur Dr A175 MC 5309 Stanford, CA 94305 Tel Work (650) 723-6961 Fax (650) 725-8418Practices at Stanford Hospital and Clinics and Lucile Packard Children's Hospital
- Academic Offices
Personal Information EmailAdministrative Contact Lu Yujuico Adminstrative Assistant Email Tel Work 650-723-6248Not for medical emergencies or patient use
Professional Snapshot
Clinical Focus
- Kidney and Pancreas Transplantation
- Nephrology
- Nephrology (Kidney)
Administrative Appointments
- Clinical Chief, Nephrology, Stanford University (1999 - present)
- Associate Chair, Stanford University School of Medicine - Medicine (2002 - 2007)
Professional Education
| Fellowship: | SUMC - Graduate Medical Education, CA (1992) |
| Board Certification: | Nephrology, American Board of Internal Medicine (1990) |
| Board Certification: | Internal Medicine, American Board of Internal Medicine (1988) |
| Residency: | Long Island Jewish Medical Center, NY (1988) |
| Internship: | Long Island Jewish Medical Center, NY (1986) |
Industry Relationships
Stanford is committed to ethical and transparent interactions with our industry partners. It is our policy to disclose payments of $5,000 or more, equity valued at $5,000 or more in a publicly traded company, or any equity in a privately held company, to physicians and scientists employed by Stanford University from companies or other commercial entities with which they interact as part of their professional activities. View Full Information
| Consulting: | Amgen, Inc. ; Bayer, inc |
Scientific Focus
Research Interests
Initiating a glomerulonephritis cohort study, including immunologic characterization. Interventional studies of preeclampsia exploring the nitric oxide, endothelin system and effects on glomerular function and morphometry. Outcome studies in dialysis and acute renal failure patients. Interventional and observational studies of glomerular disease, particularly IgA nephropathy.
Publications
- Protocol adherence and the ability to achieve target haemoglobin levels in haemodialysis patients. Nephrol Dial Transplant. 2009; (6): 1956-62
- Imatinib in the treatment of nephrogenic systemic fibrosis. Am J Kidney Dis. 2009; (1): 129-32
- Hemoglobinuria and Acute Kidney Injury Requiring Hemodialysis Following Intravenous Immunoglobulin Infusion. Am J Kidney Dis. 2009
- Facility factors dominate the ability to achieve target haemoglobin levels in haemodialysis patients. Nephrol Dial Transplant. 2008; (9): 2948-56
- Course of preeclamptic glomerular injury after delivery. Am J Physiol Renal Physiol. 2008; (3): F614-20
Help